Clinical trials
4 active studies led by Bio-Path Holdings, Inc., of 6 in all
Source: ClinicalTrials.gov, Studies with Bio-Path Holdings, Inc. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
- 0Reports naming them
- 1Markets in public records
- 0Regions & countries
- 4Active trials they lead[1]
[1] ClinicalTrials.gov, Studies led by Bio-Path Holdings, Inc. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public data on Bio-Path Holdings, Inc.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
See them on ClinicalTrials.gov (opens in a new tab)
Trials over time
Studies Bio-Path Holdings, Inc. leads, by the year they started and their phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- No phase (devices, observational)
Source: ClinicalTrials.gov, Studies with Bio-Path Holdings, Inc. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets where public records show them
Markets we cover where free public records show Bio-Path Holdings, Inc.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
Topics
The topics of the markets Bio-Path Holdings, Inc. is in.
From our blog
Stories on the topics Bio-Path Holdings, Inc. works in.
Bone and Joint Health: Supplements for an Ageing Population
1.71 billion people live with musculoskeletal conditions, including 528 million with osteoarthritis. Evidence…
Read
Vitamin D: Deficiency, Testing and Supplements
Vitamin D is made in sunlight, yet low levels are common even in sunny countries. How much you need, and when…
Read
Collagen Supplements: Skin, Joints and Real Evidence
Collagen powders promise younger skin and easier joints. A 2025 review of 23 trials found the benefits…
ReadSearch all reports for Bio-Path Holdings, Inc. All companies